About Semmelweis University, 3rd Department of Internal Medicine
A Semmelweis Egyetem II. Számú Belgyógyászati Klinika egy nagy múltú budapesti egészségügyi intézmény.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Semmelweis University, 3rd Department of Internal Medicine
During the past decade, Semmelweis University, 3rd Department of Internal Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Semmelweis University, 3rd Department of Internal Medicine"
#1 collaborator was "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Semmelweis University, 3rd Department of Internal Medicine
According to Clinical.Site data, the most researched conditions in "Semmelweis University, 3rd Department of Internal Medicine" are
"Hereditary Angioedema" (1 trials), "Metastatic Pancreatic Adenocarcinoma" (1 trials), "Multiple Myeloma" (1 trials) and "RRMM" (1 trials). Many other conditions were trialed in "Semmelweis University, 3rd Department of Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Semmelweis University, 3rd Department of Internal Medicine
Most popular intervention types in "Semmelweis University, 3rd Department of Internal Medicine" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (2 trials), "Bortezomib" (1 trials), "Gemcitabine" (1 trials), "Melphalan" (1 trials) and "ON 01910.Na" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Semmelweis University, 3rd Department of Internal Medicine
The vast majority of trials in "Semmelweis University, 3rd Department of Internal Medicine" are
4 trials for "All" genders.
Clinical Trials Status at Semmelweis University, 3rd Department of Internal Medicine
Currently, there are NaN active trials in "Semmelweis University, 3rd Department of Internal Medicine".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Semmelweis University, 3rd Department of Internal Medicine,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Semmelweis University, 3rd Department of Internal Medicine, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".